Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database

[1] Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30

[2] Miller KD(2019)Proportion of lung adenocarcinoma in female never-smokers has increased dramatically over the past 28 years J Thorac Dis 11 2685-2688

[3] Jemal A(2015)The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification J Thorac Oncol 10 1243-1260

[4] Huang C(2018)Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study J Thorac Dis 10 3595-3608

[5] Qu X(2011)International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary Proc Am Thorac Soc 8 381-385

[6] Du J(2017)Pros: the present classification of mucinous adenocarcinomas of the lung Transl Lung Cancer Res 6 230-233

[7] Travis WD(2011)Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 653-664

[8] Brambilla E(2010)Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib Lung Cancer 68 185-191

[9] Nicholson AG(2016)Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas J Thorac Oncol 11 1064-1073

[10] Yatabe Y(2013)Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients J Thorac Oncol 8 52-61

[1] Siegel RL(2020)Cancer statistics, 2020 CA Cancer J Clin 70 7-30

[2] Miller KD(2019)Proportion of lung adenocarcinoma in female never-smokers has increased dramatically over the past 28 years J Thorac Dis 11 2685-2688

[3] Jemal A(2015)The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification J Thorac Oncol 10 1243-1260

[4] Huang C(2018)Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study J Thorac Dis 10 3595-3608

[5] Qu X(2011)International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary Proc Am Thorac Soc 8 381-385

[6] Du J(2017)Pros: the present classification of mucinous adenocarcinomas of the lung Transl Lung Cancer Res 6 230-233

[7] Travis WD(2011)Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases Mod Pathol 24 653-664

[8] Brambilla E(2010)Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib Lung Cancer 68 185-191

[9] Nicholson AG(2016)Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas J Thorac Oncol 11 1064-1073

[10] Yatabe Y(2013)Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients J Thorac Oncol 8 52-61